Holen Sie sich die Stockscreener-App
90.73
2.71%
-2.53
Handel nachbörslich:
90.90
0.17
+0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$93.26
Offen:
$93.06
24-Stunden-Volumen:
5.62M
Relative Volume:
0.70
Marktkapitalisierung:
$115.76B
Einnahmen:
$407.94B
Nettoeinkommen (Verlust:
$2.90B
KGV:
39.84
EPS:
2.2771
Netto-Cashflow:
$7.39B
1W Leistung:
-3.66%
1M Leistung:
+16.41%
6M Leistung:
+13.61%
1J Leistung:
+49.15%
1-Tages-Spanne:
$90.71
$93.51
1-Wochen-Bereich:
$90.71
$96.37
52-Wochen-Spanne:
$58.50
$98.43
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
90.73 | 118.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
376.86 | 352.79B | 449.71B | 12.81B | 19.67B | 13.24 |
ELV
Elevance Health Inc
|
387.85 | 85.71B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
280.83 | 75.72B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
301.69 | 36.97B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing - The Motley Fool
CVS Health sues Tennessee pharmacy board over PBM law - Modern Healthcare
CVS Health's Aetna Cuts Complex Claims Processing Time Over 20% With New AI Platform - marketscreener.com
CVS Health (NYSE:CVS) Given New $106.00 Price Target at Barclays - MarketBeat
MinuteClinic(R) and Hartford HealthCare Expand Primary Care Access Across Connecticut - ACCESS Newswire
Aetna reduces claims processing time by more than 20% with AI to improve care experience - PR Newswire
Barclays Adjusts CVS Health Price Target to $106 From $101, Maintains Overweight Rating - marketscreener.com
Here’s What Analysts Are Saying About CVS Health Corporation (CVS) - Insider Monkey
CVS Health Valuation Puts S&P 500 Index In Focus - Kalkine Media
Legal & General Group Plc Boosts Stock Position in CVS Health Corporation $CVS - MarketBeat
Simplify Asset Management Inc. Has $5.88 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by IFP Advisors Inc - MarketBeat
Genus Capital Management Inc. Has $6.28 Million Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Price Target Boosted by $8 at Mizuho - Insider Monkey
CVS Pharmacy retail services and products explained - AD HOC NEWS
Swedbank AB Increases Stake in CVS Health Corporation $CVS - MarketBeat
82,452 Shares in CVS Health Corporation $CVS Bought by St. Louis Trust Co - MarketBeat
LSV Asset Management Sells 78,409 Shares of CVS Health Corporation $CVS - MarketBeat
Hospitals Sue CVS Health for $250M Pharmacy Scheme - planadviser
CVS sues Tennessee to halt law it says would force pharmacy closings - Yahoo! Finance Canada
[Form 4] CVS HEALTH Corp Insider Trading Activity - Stock Titan
CVS (NYSE: CVS) files Form 144 for 32,000-share compensation sale - Stock Titan
CVS (CVS) files S-3 shelf registration to offer debt securities - Stock Titan
CVS Health Sued for Allegedly Withholding Funds From Hospitals - plansponsor
House Education and Workforce Committee Advances 3 Bills - planadviser
Bernstein Sees CVS Well Positioned for Medicare Advantage Turnaround - Insider Monkey
CVS Health Collaborates With America250 To Support the Nation's 250th Anniversary Celebration - Yahoo Finance
Pzena Investment Management LLC Has $1.24 Billion Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock (US1266501006): Glenview trims stake after 80% total return and strong Q1 mom - AD HOC NEWS
CVS Health Corporation $CVS Shares Acquired by PNC Financial Services Group Inc. - MarketBeat
Banque Cantonale Vaudoise Decreases Holdings in CVS Health Corporation $CVS - MarketBeat
ABN Amro Investment Solutions Grows Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
CVS Health (CVS) Experiences Strong Returns Amid Operational Tur - GuruFocus
Larry Robbins Sells 370,462 Shares of CVS Health (NYSE:CVS) Stock - MarketBeat
CVS Health (NYSE:CVS) Director Sells $95,508,760.00 in Stock - MarketBeat
CVS Health (NYSE:CVS) Director Sells $187,345,164.10 in Stock - MarketBeat
CVS Health (NYSE: CVS) director-linked funds sell 3.75M shares and exit swaps - Stock Titan
Three major hospital systems accuse CVS of secretly siphoning hundreds of millions in drug savings - Fox Business
Glenview Capital sells 3.75M CVS shares, keeps it a top-3 holding - Stock Titan
Hospitals sue CVS Health over 340B payments - Modern Healthcare
[144] CVS HEALTH Corp SEC Filing - Stock Titan
CVS HealthYou're Not Alone: Why Maternal Mental Health Matters - ACCESS Newswire
CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey - PR Newswire
CVS Pharmacy's retail model and U.S. store network explained - AD HOC NEWS
MinuteClinic Highlights Access and Outcomes in Clinically Supervised Weight-Loss Program - ACCESS Newswire
ProShare Advisors LLC Purchases 19,018 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health stock (US1266501006): Stable Q1 growth keeps focus on margins and US healthcare demand - AD HOC NEWS
CVS Health Stock Rallies 24% in a Month as Business Turnback Fuels Rebound - NAI500
CVS Health stock (US1266501006): Mizuho lifts price target as shares hover in mid?$90s - AD HOC NEWS
Low digital health literacy hamstrings seniors' health IT use - TechTarget
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):